U.S. Health and Human Services Secretary Kathleen Sebelius “administered polio vaccination drops to children in New Delhi on Friday as India marked one year since its last case of the crippling disease,” the Associated Press reports (1/13). The Hill’s “Healthwatch” reports that “[o]fficials with the Centers for Disease Control and Prevention [CDC] say U.S. funding and experience were key to beating back the disease,” but “[t]he news comes as federal funding for global health programs now faces sharp cuts from Tea Party lawmakers and others worried about the deficit” (Pecquet, 1/12). “ÂGlobally, the U.S. government has provided $2 billion for the polio eradication campaign, Rotary International has raised about $1 billion from its members, and the Bill & Melinda Gates Foundation has donated more than $1 billion,” and the CDC “weighed in with crucial expertise,” the Washington Post writes (Denyer, 1/12).
“Nigeria’s 36 Executive Governors and the Federal Capital Territory have signed up to the Nigeria Immunization Challenge launched by the Bill & Melinda Gates Foundation last year,” a Gates Foundation press release states. “The Nigeria Immunization Challenge sets specific objectives that need to be met during each quarter of 2012. If met, Nigeria will significantly improve its chances of stopping polio and protecting more children against vaccine-preventable diseases such as measles and whooping cough,” the release adds, noting, “As of December 30, 2011, 51 cases of wild poliovirus had been reported in eight Nigerian states” (1/5).
This post in the U.N. Foundation’s “Shot@Life” blog examines how Honduras, “one of the poorest countries in the Western hemisphere,” has achieved “one of the highest vaccination coverage rates in the world, averaging close to 99 percent.” The blog writes, “We wanted to see firsthand how Honduras has achieved such amazing results, so last week Shot@Life traveled there with a U.S. Congressional staff delegation to learn more about their extremely effective immunization programs” and details the vaccination efforts of the rural town La CaÃ±ada (Willingham, 1/23).
Further Examination Of Key Findings Of Policy Innovation Memorandum On Safety Of World Drug, Vaccine Supply
In this post on her blog, “The Garrett Update” — the last of a series of posts examining the safety of drugs and vaccines — Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), further details the key findings of the CFR’s Policy Innovation Memorandum No. 21, a six-point policy recommendation for the G8/20 that she authored, titled “Ensuring the Safety and Integrity of the World’s Drug, Vaccine, and Medicines Supply.” She concludes, “The crisis is global, growing and massive. Unless international solutions are eagerly embraced, such as we and others have recommended, the very integrity of Medicine and Public Health will be undermined amid a steadily rising toll of illnesses and deaths ascribed to bad medicines” (May 2012).
In this editorial in the International Herald Tribune’s “Express Tribune,” U.N. Secretary-General Ban Ki-moon examines the global push to eradicate polio, highlighting progress in the “world’s war on polio” since it was declared nearly a quarter century ago but warning that “we are in danger of falling victim to our own success,” as “the world is now populated by a generation which has either never been exposed to polio or has been inadequately vaccinated.” However, “[w]ith a determined push, the international community can wipe out polio once and for all,” Ban continues, adding, “To do so, … it must organize and commit the required financial resources.” Ban highlights two upcoming meetings — the G8 summit at Camp David this week, and a meeting of World Health Assembly in Geneva the following week — as opportunities for world leaders to push for polio eradication on the international agenda.
In this post in USAID’s “IMPACTblog,” International AIDS Vaccine Initiative (IAVI) President and CEO Margaret McGlynn discusses new modeling data from IAVI and the Futures Institute, with support from USAID, which “illustrates how a safe, preventive HIV vaccine that is accessible and affordable can help us end the AIDS pandemic.” The information, released in recognition of World AIDS Vaccine Day, also known as HIV Vaccine Awareness Day, “is available in a series of publications and an interactive web tool,” according to McGlynn. She writes, “The world must continue to scale up and improve the response to HIV by using powerful prevention tools that are currently at our disposal. … Our new models show that a vaccine can build on these existing tools and take us down the last mile to the end of the AIDS pandemic” (5/18).
In this post in PSI’s “Healthy Lives” blog, Deputy Editor Tom Murphy examines routine vaccination solutions in Nigeria, where “[t]he Decade of Vaccines Economics projects 90 percent vaccine coverage against Hib, pneumococcal disease, rotavirus, measles and pertussis can save 600,000 lives and $17 billion in Nigeria over the next 10 years.” Murphy highlights a “new report [.pdf] by the International Vaccine Access Center (IVAC) at Johns Hopkins University [that] identifies the challenges and solutions to increasing routine vaccinations in” the country, noting it also “identifies supply, human resource and demand solutions to increasing vaccination access” (5/8).
“A vaccine against one of the most neglected yet fatal tropical diseases is being tested for the first time in a clinical trial in India and the U.S.,” IRIN reports. Visceral leishmaniasis (VL), “also called kala-azar or black fever, infects an estimated half million persons or more annually,” and “[i]t is found most commonly in India, Nepal, Bangladesh, Brazil and Sudan,” the news service notes. “A total of 72 volunteers are participating in the trial, but scientists say it will take years of testing to roll out an affordable vaccine to the 200 million people globally at risk of VL infection,” IRIN writes, adding, “The WHO has warned that VL is spreading to previously unaffected countries due to co-infections of HIV and leishmaniasis, while the Intergovernmental Panel on Climate Change (IPCC) has said climate change can also spur the spread of the disease” (5/9).
Millennium Villages Project Research Yields Positive Results, But Some Researchers Question Methods Used
“Death rates among children under five at the [Millennium Villages Project (MVP)] — set up in Africa to demonstrate what is possible if health, education, agriculture, and other development needs are tackled simultaneously — have fallen by a third in three years compared with similar communities, according to the project’s first results,” published in the Lancet on Tuesday, the Guardian reports (Boseley, 5/8). The study “offers quantitative evidence of the success of the MVP model at nine Millennium Village sites in sub-Saharan Africa,” Nature News writes, adding, “Between 2006 and 2009, mortality in under-fives fell by an average of 22 percent, reaching a level roughly two-thirds of that in control villages not involved with the project, where child mortality seemed to rise.”
“The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines,” Laurie Garrett, senior fellow for global health at the Council on Foreign Relations (CFR), writes in the council’s Policy Innovation Memorandum No. 21, titled, “Ensuring the Safety and Integrity of the World’s Drug, Vaccine, and Medicines Supply.” According to the memorandum, “Unless this issue is addressed, millions more lives and the credibility of medicines and vaccines will be lost. The Groups of Eight (G8) and Twenty (G20) countries should take the lead, as a matter of urgency, in promoting cooperation among national safety regulators, tougher legal frameworks, and regional networks of surveillance and prosecution” (May 2012).